SEC Form 4 · accession 0001209191-16-148873
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy J. Ackerman
Officer — SVP, Commercial Operations
Period of report
Nov 5, 2016
Accepted (ET)
Nov 8, 2016 · 4:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Nov 5, 2016 | M | 2,500 | — | A | 32,232 | D | |
| Ordinary Shares | Nov 5, 2016 | F | 778 | $15.05 | D | 31,454 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F3 | — | Nov 5, 2016 | M | 2,500 | D | — | — | Ordinary Shares | 2,500 | 5,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- F2Includes 2,051 ordinary shares of the Issuer acquired by the reporting person on June 1, 2016 pursuant to an employee stock purchase program.
- F3On November 5, 2014, the reporting person was granted 10,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.